chrisvoncsefalvay/vaers-outcomes huggingface dataset:
aches; fever; This is a spontaneous report from a contactable consumer. An unspecified age and gender patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had fever, and aches. She said she did not have the same side effects and did not have any severe reaction after her 1st dose of the vaccine. She wants to know if not having side effects mean that there is a problem with her immune response. The outcome of the events was unknown.  Information on the Batch/Lot number has been requested.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a 68 year old female patient. On 13-MAY-2014, the patient was vaccinated with a dose of ZOSTAVAX (lot # L003217, expiration date 30-APR-2016, 0.65 ml, subcutaneously). ON 15-MAY-2014, the patient experienced urinary tract infection. The patient sought medical attention: saw unspecified physician. CIRPO was given as a treatment of the event. The outcome of urinary tract infection was unknown. Relatedness between the event and a vaccination with ZOSTAVAX was not reported. Additional information has been requested.
Dosing schedule was interrupted by a year; This non-serious case was reported by a other health professional via other manufacturer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient did not receive Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Dosing schedule was interrupted by a year). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The health care professional (HCP) stated they may had a patient who had a dose interruption with the vaccine Shingrix. Limited information was available as HCP refused to answer questions such as dates and demographics.  The HCP stated that the a possible patients dosing schedule was interrupted by a year. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Due to limited information, the case was processed conservatively for incomplete course of vaccination.
Hives on legs, shoulder, abdomen that are intermittent. patient seen in clinic on 11/12/14 with hives on leg, no respiratory symptoms.  Benadryl and topical steroid prescribed.
Approximately 20 minutes after administration of DTAP in left thigh, patient develops hives and purplish feet.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender (encounter key #40054). The patient's concurrent conditions and medical history were not provided. On 15-OCT-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (VIs 10 SDV) (Lot # K007822, expiration date 15-AUG-2015) single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, PNEUMOVAX had a temperature excursion for 504 hours, the lowest recorded temperature was 20F (-6.667 Celsius). The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
Syncope, collapse, seizure, amnesia, brain fog, migraine, nausea, vomiting, double vision; all ongoing since time of second dose administration
2 days after the first shot, I got a scratchy throat and cold symptoms that lasted about a week.  I was very run down and exhausted.  On July 21, about 3 weeks after my second dose, I had to have paramedics come to my office as my arms and legs started losing feeling and something felt very wrong.  They checked my heart, blood sugar and blood pressure.  All was fine, except my blood pressure settled down after a few hours and went back to normal (110 over 80).  I followed up with my doctor and had some blood work done the same day.  All checked out fine, but I immediately started having dizziness and vertigo symptoms.  No cause could be found.  The dizziness and vertigo lasted for nearly 3 weeks and I could not be my normal, active self.  I am normally a very healthy person and I have not had any health issues.  These symptoms came on suddenly and the only thing I have done differently in my life lately is get vaccinated.  I felt this need to be reported in case anyone else has experience something similar.
Nurse administered flu vaccine at 2:30 PM. Patient had increased anxiety before shot was given. Nuirse had patient wait after administering flu vaccine and patient complained of feeling hot. Had patient remove sweatshirt and applied cold rag to back of the neck. Elevated patients legs. Patient was still feeling dizzy. Nurse placed patient on floor and elevated legs. Patient continued to complain of dizziness. BP 120/84, pulse 80, resp 24. Called EMS at 3:15 PM. EMS arrived at 3:25 PM. EMS assessed the patient and decided to take patient to the emergency room.
Pt was seen 6/8/09 for 5 year WCC and received MMR, VZV, PV, DTaP, Hib and Hep A. He woke up this a.m. c/o itchy red rash on (L) upper thigh which became red and warm.
pt recv vax & later felt funny-dizzy, then passed out;co-worker reported body shaking & eyes rolling;taken to ER via amb;5NOV96 pt reported was sneezing & w/cold-like sx;6NOV96 whole body weak, h/a, scratchy throat, tired;
This report was received from manufacturer for Pediarix and was assigned manufacturer control number A0505621A.This report concerns a 9 week old female patient with no allergies and no known past medical history who on 03/16/2004 was vaccinated with a first dose of Hib conj vaccine (OMPC) (manufacturer unk). Concomitant vaccination on 03/16/2004 included a first 0.5ml dose of diphtheria toxoid(+)hepatitis B virus vaccine rHBsAg (yeast)(+)pertussis acellular 3-component vaccine (+) poliovirus inactivated (Vero)(+) tetanus toxoid (Pediarix)(lot#21883B2) amd a first dose of pneumococcal 4 6B 9V 18C 19F 23F conj vaccine (crm197)(Prevnar). There was no illness at the time of vaccination. It was noted this was the patient's first set of vaccinations and she was the first baby born to a young couple. The reporter stated the patient inadvertently received first 0.5ml dose of diphtheria toxoid(+) hepatitis B virus vaccine rHBsAg(yeast)(+)pertussis acellular 3-component vaccine (+) poliovirus vaccine inactivated (Vero)(+)tetanus toxoid (Pediarix)(lot#21883B2) that was past the labeled expiration date of 03/11/2004. Subsequently on 03/16/2004, the patient developed irritability. The parents thought the patient was more irritable than she should have been. Medical attention was not sought, laboratory tests were not performed and no treatment was given. The irritability lasted only the evening of the vaccinations. On 03/16/2004, the irritability resolved with no other problems. This was originally reported by a registered nurse. Additional information is not expected.
Pain all over her body; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain all over her body) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN (Pain all over her body) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Pain all over her body) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Kind of tired; Very thirsty; Bleeding nose; Very dry throat; Big strong headaches; Could not sleep; She had to pee a lot; Pressure on chest; This is a spontaneous report from a non-contactable consumer (patient). This non-contactable female consumer reported for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot Number: EW0187), via an unspecified route of administration on an unspecified date as unknown, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient stated, the side effects she has been experiencing for the last 3 days. She received her vaccine on the first of this month. She began experiencing heavy side effects. They were kind of tired. After the 11th day, she was very thirsty. She drank 2 cups of tea and 5 glasses of big water at nighttime. She had to pee a lot. Her throat was not sore, but it was very dry. Before that, she went back to the library studying. When she arrived home, she experienced a bleeding nose. She thought her mucus was very dry. Her nose was bleeding for quite a bit and then it stopped. During the night, she began experiencing a lot of big strong headaches. She could not sleep. The thirstiness and she got pressure on her chest. It was like when someone is walking very fast and breathing. She managed to get through the night. The patient was recovered from bleeding nose and outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Achy, fatigue, slight SOB, and rash on chest. Ibuprofen and antihistamine helped relieve all symptoms except rash. Rash is still present and itchy 32 hrs post vaccine.
Redness at injection site; Itching at the injection site; Arm soreness; 1st dose Oct2021, 2nd not yet; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In October 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced injection site erythema, injection site itching, pain in arm and incomplete course of vaccination. On an unknown date, the outcome of the injection site erythema, injection site itching and pain in arm were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the injection site erythema, injection site itching and pain in arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 09-JAN-2023 Reporter's Comments: The patient reported case for herself. The patient receiving first dose of Shingrix in October of 2021 and having not yet received the second dose.  The patient was experienced arm soreness, redness, and itching at the injection site after the first dose.  The patient reported all symptoms experienced after the first dose have resolved.  The reporter did not consent to follow-up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Two hours after injection, itching rash on chest then abdomen and back. Itching and rash progressed over next week to neck scalp, forehead, ears and eyelids.  Day 8 injection site turned bright red and hot. Redness was circumference of tennis ball. Also itching.  At two weeks in some rash and itching continue, especially at night.  Most intense rash and itching at the fold of each armpit just above each breast.
Itchy at site/slightly swollen. BENADRYL 25 mg po 17:15.  128/80, p 82, r 20. No resp problems-denied other symptoms. Stayed in bldg just under 1 hr, 16:30-17:25 before released.
since you poisoned me and I wanna kill myself! Well, you gave it to me and I'm going to kill myself; peg allergy after getting the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (Unknown). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUICIDAL IDEATION (medically significant, life threatening), outcome "unknown", described as "since you poisoned me and I wanna kill myself! Well, you gave it to me and I'm going to kill myself"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "PEG (Polyethylene Glycol) allergy after getting the vaccine". The events "since you poisoned me and i wanna kill myself!  Well, you gave it to me and I'm going to kill myself" and "peg allergy after getting the vaccine" required physician office visit. Course of events: A patient was asking for information on an antidote or medication for PEG allergy after getting the vaccine. She has consulted her healthcare provider a hundred times, they don't have any treatment. She wanted to know if there is a treatment (for peg allergy), "since you poisoned me and I wanna kill myself! Well, you gave it to me and I'm going to kill myself and hold you responsible".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fainted on 11/16/2009. Lightheaded on 11-19-2009. No prev. condition w/fainting.
A non-serious spontaneous report of administration of expired product was received from a health professional concerning a five-year-old male. Neither past medical history nor concomitant medications were reported for this patient. The product expired on 02-Dec-2010. On 06-Dec-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information received on 21-Apr-2011 and incorporated into case: no late occurring adverse events.
Pt developed edema from shoulder to elbow, erythema, soreness, had difficult sleeping that night. Instructed to apply cold compresses (swelling lasted 2 days).
This case was reported by a consumer via interactive digital media and described the occurrence of unwell in a female patient who received Flu Seasonal QIV Dresden for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced unwell. On an unknown date, the outcome of the unwell was unknown. It was unknown if the reporter considered the unwell to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. After receiving the flu shot the patient got ill.
1/2 hour post injection got severe headache took asa with no relief.  5 1/2 hour post injections began trembling and had fatigue. 6 hours unable to ambulate. Within next 12 hours s/s  resolved pt did not seek medical attention.
not eating right; not hungry; always cold; get real hot and start sweating; feeling weak; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), DECREASED APPETITE (not eating right), DECREASED APPETITE (not hungry), FEELING COLD (always cold) and HYPERHIDROSIS (get real hot and start sweating) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced DECREASED APPETITE (not eating right), DECREASED APPETITE (not hungry), FEELING COLD (always cold), HYPERHIDROSIS (get real hot and start sweating), ASTHENIA (feeling weak) and CHILLS (chills). At the time of the report, HEADACHE (headache), DECREASED APPETITE (not hungry), FEELING COLD (always cold), HYPERHIDROSIS (get real hot and start sweating), ASTHENIA (feeling weak) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.
Moderna COVID-19 Vaccine EUA   Fever of 104 for approx 8 hours,  joint pains and body aches. Reddness and swelling at injection site.   Fever responded after 3 doses of Tylenol, and a dose of Benadryl.  Following day no joint aches or fever.  Swelling , warmth and slight pain continues at injection site.
15 hours after the vaccination, I woke up with nausea and chills. After an episode of loose stool with dry heaving, I stood up and fainted, coming to on my left side. After this, I had chills and a sore arm for 24 hours. I also had fatigue, brain fog, and intermittent dizziness that persisted. I saw my PCP on 10/26 and had a head CT on 10/29 when I was still intermittently dizzy and fatigued, especially when moving from supine to standing, or standing for some time. The dizziness lasted until 11/5.
Information has been received from a physician who on an unspecified date was vaccinated with a first dose of zoster vaccine live (Oka/Merck). Subsequently, sometime last week on approximately 08-APR-2008 he experienced swelling, pain, and redness at the injection site after receiving the vaccination. It was unspecified if medical attention was sought. At the time of the report the patient had not recovered. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source.
On 2/21/21 I had severe abdominal pain that lasted for 10 hours.  The pain came back on 2/33/21, and moved from the abdomen to the left side.  When I was unable to sit or stand or lie down, I went to the Hospital ER.  They did a CAT scan, and found a splenic infarct.
Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 04-MAR-2022; Patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 04-MAR-2022) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     Acute illness at the time of vaccination and up to one month before was reported as unknown. Chronic or long-standing health conditions was reported as unknown.     On 04-Mar-2022 at 9:36 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Mar-2022 at 9:36 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 04-MAR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 04-MAR-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination  or at the time of the adverse event were reported as unknown. Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown. It was reported that the vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and the patient took booster dose. No treatment information was reported.   This case was linked to MOD-2022-542869 (Patient Link).
crying all noc on 9JAN96 not eating;vomited x2; fever of 103.0R till AM 10JAN96;spitting up breast milk when feeding;
Rash, swollen elbow and forearm, slight fever, headache, numbness in hand, treated with Augmentin, swelling reduced 4/2/00.  Positive for cellulitis.
Information has been received from a nurse concerning a 21 year old female who on 19-APR-2007 was vaccinated with Gardasil (Lot#657622/0388U). On 19-APR-2007 the patient experienced deep muscle pain, her arm still hurts and she cannot lift her arm to dress. It was reported that the patient sought unspecified medical attention. No further details were provided. Follow up information provided by a medical professional stated that on 02-MAY-2007 the patient had daily discomfort only in her deltoid where the injection had been given. At the time of this report it was reported that the patient had not recovered from the discomfort. Additional information has been requested.
This initial report was received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 06-JUN-2017, the patient was vaccinated with an expired dose of M-M-R II, subcutaneous route, lot number L020189 with expiration date 06-JUN-2017 for prophylaxis (dose and strength were not reported). No known adverse events were reported. Additional information has been requested.
Note 1: Initial Fatigue and fuzziness in my head - temperature was slightly elevated; headache, sore throat, feeling feverish and nauseous - cleared up within about 24 hours and it was the second 24 hours after the shot. No sign of anything the day of the shot. Note 2: There is a chance I had COVID 6 months before the vaccine, November 2019 - my son had been away on 10/26/2019 and someone was sick in back of him on the plane and everyone in my family became ill after that. I mostly just had a runny nose for symptoms and had lost my sense of smell (it actually smelled rotten).  March 2021 - Got sick two weeks after the COVID vaccine -  Every injury I ever had: inflammation in all my joints - all my sprains I ever had  were inflamed- so I couldn't walk. I got an elevated temperature (but not a bad fever); heart was doing "flip flops"  -not beating regularly- worse when sitting and would go away when I stood up but my heart rate seemed to be normal;  had gastric distress - diarrhea and then two days later, I felt light headed and dizzy and visual migraines. Breathing exercises helped.  I was worried that my heart may stop when I was sleeping with the flips flops - it was pretty scary at the time. I tried to go to the urgent clinic but it was a Saturday when I called and they were closed and then I started feeling better by and decided to get a second vaccine at the regular time on 3/29/2021.